BIO-UV Group Statistics

Total Valuation

BIO-UV Group has a market cap or net worth of EUR 28.47 million. The enterprise value is 48.59 million.

Market Cap	28.47M
Enterprise Value	48.59M

Important Dates

The next estimated earnings date is Friday, June 20, 2025.

Earnings Date	Jun 20, 2025
Ex-Dividend Date	n/a

Share Statistics

BIO-UV Group has 13.82 million shares outstanding. The number of shares has decreased by -0.58% in one year.

Current Share Class	13.82M
Shares Outstanding	13.82M
Shares Change (YoY)	-0.58%
Shares Change (QoQ)	+2.86%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	8.38%
Float	13.65M

Valuation Ratios

The trailing PE ratio is 907.89.

PE Ratio	907.89
Forward PE	n/a
PS Ratio	0.74
PB Ratio	0.87
P/TBV Ratio	87.41
P/FCF Ratio	5.74
P/OCF Ratio	4.13
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.06, with an EV/FCF ratio of 9.79.

EV / Earnings	1,549.38
EV / Sales	1.26
EV / EBITDA	18.06
EV / EBIT	22.79
EV / FCF	9.79

Financial Position

The company has a current ratio of 1.64, with a Debt / Equity ratio of 0.73.

Current Ratio	1.64
Quick Ratio	0.69
Debt / Equity	0.73
Debt / EBITDA	8.92
Debt / FCF	4.83
Interest Coverage	2.75

Financial Efficiency

Return on equity (ROE) is 0.10% and return on invested capital (ROIC) is 2.27%.

Return on Equity (ROE)	0.10%
Return on Assets (ROA)	1.94%
Return on Invested Capital (ROIC)	2.27%
Return on Capital Employed (ROCE)	4.13%
Revenue Per Employee	259,660
Profits Per Employee	210
Employee Count	149
Asset Turnover	0.56
Inventory Turnover	1.11

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.81% in the last 52 weeks. The beta is 0.40, so BIO-UV Group's price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	-8.81%
50-Day Moving Average	1.83
200-Day Moving Average	1.93
Relative Strength Index (RSI)	66.63
Average Volume (20 Days)	14,685

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BIO-UV Group had revenue of EUR 38.69 million and earned 31,361 in profits. Earnings per share was 0.00.

Revenue	38.69M
Gross Profit	24.09M
Operating Income	2.13M
Pretax Income	92,287
Net Income	31,361
EBITDA	2.69M
EBIT	2.13M
Earnings Per Share (EPS)	0.00

Full Income Statement

Balance Sheet

The company has 3.87 million in cash and 23.99 million in debt, giving a net cash position of -20.12 million or -1.46 per share.

Cash & Cash Equivalents	3.87M
Total Debt	23.99M
Net Cash	-20.12M
Net Cash Per Share	-1.46
Equity (Book Value)	32.69M
Book Value Per Share	3.26
Working Capital	9.22M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.90 million and capital expenditures -1.94 million, giving a free cash flow of 4.96 million.

Operating Cash Flow	6.90M
Capital Expenditures	-1.94M
Free Cash Flow	4.96M
FCF Per Share	0.36

Full Cash Flow Statement

Margins

Gross margin is 62.28%, with operating and profit margins of 5.51% and 0.08%.

Gross Margin	62.28%
Operating Margin	5.51%
Pretax Margin	0.24%
Profit Margin	0.08%
EBITDA Margin	6.95%
EBIT Margin	5.51%
FCF Margin	12.83%

Dividends & Yields

BIO-UV Group does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.58%
Shareholder Yield	n/a
Earnings Yield	0.11%
FCF Yield	17.43%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BIO-UV Group has an Altman Z-Score of 1.25. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.25
Piotroski F-Score	n/a